黑料门

CopilotIQ and 黑料门 have merged to create the first end-to-end platform for AI-driven in-home care. To learn more about how we are working together to shape the future of healthcare .

Vital innovations that bring the right care to everyone, everywhere

With our connected technology platform, we partner with health systems and pharmaceutical companies to revolutionize the delivery of care and drug development across the care continuum.

Learn more about our solutions

With our connected technology platform, we partner with health systems, risk-bearing organizations, and life science companies to revolutionize drug life cycle management and delivery of care across the continuum.

Learn more about our solutions

CopilotIQ and 黑料门 have merged to create the first end-to-end platform for AI-driven in-home care. To learn more about how we are working together to shape the future of healthcare .

Vital innovations that bring the right care to everyone, everywhere

With our connected technology platform, we partner with health systems and pharmaceutical companies to revolutionize the delivery of care and drug development across the care continuum.

Learn more about our solutions

With our connected technology platform, we partner with health systems, risk-bearing organizations, and life science companies to revolutionize drug life cycle management and delivery of care across the continuum.

Learn more about our solutions

Merger Announcement

CopilotIQ and 黑料门 merge to create the first
end-to-end platform for AI-driven in-home care.

Learn More

Connecting solutions to step up care

黑料门 addresses challenges impacting the health and pharmaceutical industries today across the continuum from drug development to care delivery. By delivering and transitioning patients across levels of care, clinical trials, and drug companions, our solutions offer patients continuity of care and more care options.聽Our partners rely on 黑料门 for streamlined services, access to targeted patient populations, and improved economic, operational, and clinical outcomes.

Learn about 黑料门 Platform
From Drug Development
To Care Delivery

Expanding clinical trial access

Addressing hospital capacity

Solving staffing shortages

Optimizing medication management

Advancing drug commercialization

Increasing patient engagement

Managing chronic conditions

Expanding clinical trial access

Optimizing medication management

Advancing drug commercialization

Addressing hospital capacity

Solving staffing shortages

Managing chronic conditions

Increasing patient engagement

From Drug Development
To Care Delivery

Addressing hospital capacity

Expanding clinical trial access

Solving staffing shortages

Optimizing medication management

Managing chronic conditions

Advancing drug commercialization

Increasing patient engagement

From Drug Development
To Care Delivery

Making home the site of care

Our technology-enabled solutions empower patients to receive care at home, and easily transition between levels and locations of care. Outcomes have shown clinical, operational, and economic improvements such as a 70% reduction in 30-day readmissions, the ability to detect deterioration 21 hours sooner, and reductions in cost of care by up to 38%1,2.

01
Hospital at Home
02
Timely Discharge
03
SNF聽at home
04
Remote Patient Management
Hand holding a phone displaying the 黑料门 platform.
One hand holding a pill bottle and another hand outstretched.

Managing the drug life cycle

We enable life science companies to deliver clinical trials anywhere, and to commercialize novel therapies and digital health products.*

01
Digital clinical trials
02
Digital drug companions聽
03
Digital measures, biomarkers, and endpoints

Our collaborators in the healthcare-delivery revolution

We partner with more than 50 global health systems, life science companies, and payers to expand access to care and therapeutics in their communities.
Flattened map of globe

Expanding access to care worldwide

We partner with more than 50 health systems, pharmaceutical companies, and payers to expand access to care and therapeutics in their communities worldwide.

25
U.S. States with licensed operations
31
countries worldwide operating clinical trials

1. Un, KC., Wong, CK., Lau, YM. et al. Observational study on wearable biosensors and machine learning-based remote monitoring of COVID-19 patients. Sci Rep 11, 4388 (2021). .
2. Levine DM, Ouchi K, Blanchfield B, Saenz A, Burke K, Paz M, Diamond K, Pu CT, Schnipper JL. Hospital-Level Care at Home for Acutely Ill Adults: A Randomized Controlled Trial. Ann Intern Med. 2020 Jan 21;172(2):77-85. doi: 10.7326/M19-0600. Epub 2019 Dec 17. PMID: 31842232.

*Subject to geography and connectivity